Alternatives to Amendis

GeneDx is a leading provider of genomic testing and interpretation services for rare and common diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

AI-powered spatial biology platform for precision medicine and drug development.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Harnessing genetic data for digital insights in rare and germline disorders.

AI-powered cancer detection and therapy solutions for early diagnosis and personalized risk assessment.

AI-powered blood test for early cancer detection and subtyping.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

Developing novel diagnostics to predict patient response to immunotherapy.

AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.